In a survey of nearly 1,200 recent cancer patients and survivors conducted as part of the American Cancer Society Cancer Action Network’s Survivor Views project, more than 80% of respondents said they would be willing to use remote technologies and tools in a trial.
Sarah Bigelow was named executive director of the Clinical Trials Office at the Tulane Cancer Center.
